The apelin receptor APJ: Journey from an orphan to a multifaceted regulator of homeostasis

Journal of Endocrinology

Volumn 219, Issue 1, 2013, Pages

  O'Carroll, Anne Marie ^a   Lolait, Stephen J ^a   Harris, Louise E ^a   Pope, George R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Apelin; APJ; G protein coupled receptor; Homeostasis

Indexed keywords

APELIN; APELIN 13; APELIN 17; APELIN 36; APELIN RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN KINASE C; RAF PROTEIN; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADRENAL GLAND; ANGIOGENESIS; ANXIETY DISORDER; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BLADDER; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL SURVIVAL; CEREBELLUM; CLAUSTRUM; COLON; CONGESTIVE CARDIOMYOPATHY; CORPUS CALLOSUM; DEPRESSION; DNA FLANKING REGION; ENDOTHELIUM CELL; ENERGY METABOLISM; ESSENTIAL HYPERTENSION; EXTRACELLULAR SPACE; FLUID BALANCE; FRONTAL CORTEX; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC SUSCEPTIBILITY; GLUCOSE TRANSPORT; HEART FAILURE; HEART VENTRICLE SEPTUM DEFECT; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYPOPHYSIS; HYPOTHALAMUS; INSULIN SENSITIVITY; INTESTINE; INTRON; KIDNEY; LIGAND BINDING; LIVER; LUNG; MAMMARY GLAND; MEAN ARTERIAL PRESSURE; MESENCEPHALON; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OLFACTORY BULB; OSTEOBLAST; OVARY; OXIDATIVE STRESS; PALMITOYLATION; PANCREAS; PATHOPHYSIOLOGY; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECOND MESSENGER; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD; SPLEEN; STOMACH; STRESS; SUBSTANTIA NIGRA; TESTIS; THALAMUS; THALAMUS NUCLEUS; THYMUS; UTERUS; VASOCONSTRICTION;

APELIN; APJ; G PROTEIN-COUPLED RECEPTOR; HOMEOSTASIS;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HOMEOSTASIS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; OBESITY; PHOSPHATIDYLINOSITOL 3-KINASES; PITUITARY-ADRENAL SYSTEM; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84884180829     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0227     Document Type: Article

References (194)

1. Albizu L, CottetM, KralikovaM, Stoev S, Seyer R, Brabet I, Roux T, Bazin H, Bourrier E, Lamarque L et al. 2010 Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nature Chemical Biology 6 587-594. (doi:10.1038/nchembio.396)
2. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, Deng A, Eichhorn J, Mahajan R, Agrawal R et al. 2005 The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovascular Research 65 73-82. (doi:10.1016/ j.cardiores.2004.08.018)
3. Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, HiesingerW, Cohen JE & Joseph Woo Y 2007 Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cellular and Molecular Biology Letters 12 127-138. (doi:10.2478/s11658- 006-0058-7)
4. Attane C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E, Guzman-Ruiz R, Dray C, Bezaire V, Rancoule C et al. 2012 Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 61 310-320. (doi:10.2337/db11-0100)
5. Azizi M, IturriozX, BlanchardA, Peyrard S,DeMotaN,ChartrelN, VaudryH, Corvol P&Llorens-CortesC2008 Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. Journal of the American Society of Nephrology 19 1015-1024. (doi:10.1681/ASN.2007070816)
6. Azizi Y, Faghihi M, Imani A, Roghani M & Nazari A 2013 Post-infarct treatment with [Pyr]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction. Peptides 46 76-82. (doi:10.1016/ j.peptides.2013.05.006)
7. Bae YS, Oh H, Rhee SG & Yoo YD 2011 Regulation of reactive oxygen species generation in cell signaling. Molecules and Cells 32 491-509. (doi:10.1007/s10059-011-0276-3)
8. Bai B, Tang J, Liu H, Chen J, Li Y & SongW2008 Apelin-13 induces ERK1/2 but not p38 MAPK activation through coupling of the human apelin receptor to the Gi2 pathway. Acta Biochimica et Biophysica Sinica 40 311-318. (doi:10.1111/j.1745-7270.2008.00403.x)
9. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ & Woo YJ 2004 Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 II187-II193. (doi:10.1161/01.CIR. 0000138382.57325.5c)
10. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C et al. 2005 Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 1764-1771. (doi:10.1210/en.2004-1427)
11. Brailoiu GC, Dun SL, Yang J, Ohsawa M, Chang JK & Dun NJ 2002 Apelinimmunoreactivity in the rat hypothalamus and pituitary. Neuroscience Letters 327 193-197. (doi:10.1016/S0304-3940(02)00411-1)
12. Burbach JP, Luckman SM, Murphy D & Gainer H 2001 Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiological Reviews 81 1197-1267.
13. Castan-Laurell I, VitkovaM, Daviaud D, Dray C, Kovacikova M, Kovacova Z, Hejnova J, Stich V & Valet P 2008 Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. European Journal of Endocrinology 158 905-910. (doi:10.1530/EJE-08-0039)
14. Cavallo MG, Sentinelli F, Barchetta I, Costantino C, Incani M, Perra L, Capoccia D, Romeo S, Cossu E, Leonetti F et al. 2012 Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus. PLoS ONE 7 e51236. (doi:10.1371/journal.pone. 0051236)
15. Chang CY, Tsai YC, Lee CH, Chan TF, Wang SH & Su JH 2011 Lower serum apelin levels in women with polycystic ovary syndrome. Fertility and Sterility 95 2520-2523. (doi:10.1016/j.fertnstert.2011.04.044)
16. Charles CJ, Rademaker MT & Richards AM 2006 Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep. Journal of Endocrinology 189 701-710. (doi:10.1677/ joe.1.06804)
17. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM et al. 2009 Endogenous regulation of cardiovascular function by apelin-APJ. American Journal of Physiology. Heart and Circulatory Physiology 297 H1904-H1913. (doi:10.1152/ajpheart.00686.2009)
18. Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY et al. 2003 Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108 1432-1439. (doi:10.1161/01.CIR.0000091235. 94914.75)
19. Chen H, Zheng C, Zhang X, Li J, Li J, Zheng L & Huang K 2011 Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice. Peptides 32 1634-1639. (doi:10.1016/j.peptides. 2011.06.025)
20. Cheng X, Cheng XS & Pang CC 2003 Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. European Journal of Pharmacology 470 171-175. (doi:10.1016/ S0014-2999(03)01821-1)
21. Cheng B, Chen J, Bai B & Xin Q 2012 Neuroprotection of apelin and its signaling pathway. Peptides 37 171-173. (doi:10.1016/j.peptides.2012. 07.012)
22. Choe H, Farzan M, Konkel M, Martin K, Sun Y, Marcon L, Cayabyab M, Berman M, Dorf ME, Gerard N et al. 1998 The orphan seventransmembrane receptor apj supports the entry of primary T-cell-linetropic and dualtropic human immunodeficiency virus type 1. Journal of Virology 72 6113-6118.
23. Choe W, Albright A, Sulcove J, Jaffer S, Hesselgesser J, Lavi E, Crino P & Kolson DL 2000 Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. Journal of Neurovirology 6(Suppl 1) S61-S69.
24. Chong KS, Gardner RS,Morton JJ, Ashley EA &McDonagh TA 2006 Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. European Journal of Heart Failure 8 355-360. (doi:10.1016/j.ejheart.2005.10.007)
25. Chu J, Zhang H, Huang X, Lin Y, Shen T, Chen B, Man Y, Wang S & Li J 2013 Apelin ameliorates TNF-a-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. PLoS ONE 8 e57231. (doi:10.1371/journal.pone.0057231)
26. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, Zheng L, Leeper NJ, Pearl NE, Patterson AJ et al. 2008 Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. Journal of Clinical Investigation 118 3343-3354. (doi:10.1172/JCI34871)
27. Clarke KJ, Whitaker KW & Reyes TM 2009 Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet. Journal of Neuroendocrinology 21 83-89. (doi:10.1111/ j.1365-2826.2008.01815.x)
28. Coskun ZM, Sacan O, Karatug A, Turk N, Yanardag R, Bolkent S & Bolkent S 2013 Regulation of oxidative stress and somatostatin, cholecystokinin, apelin gene expressions by ghrelin in stomach of newborn diabetic rats. Acta Histochemica [in press]. (doi:10.1016/j.acthis.2013.03.001)
29. Cox CM, D'Agostino SL, Miller MK, Heimark RL & Krieg PA 2006 Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Developmental Biology 296 177-189. (doi:10.1016/ j.ydbio.2006.04.452)
30. Cui RR, Mao DA, Yi L, Wang C, Zhang XX, Xie H,Wu XP, Liao XB, Zhou H, Meng JC et al. 2010 Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways. Amino Acids 39 1193-1200. (doi:10.1007/s00726-010-0555-x)
31. Dai L, Smith PM, Kuksis M & Ferguson AV 2013 Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function. Journal of Physiology 591 3421-3432. (doi:10.1113/jphysiol. 2013.254144)
32. D'Aniello C, Lonardo E, Iaconis S, Guardiola O, Liguoro AM, Liguori GL, Autiero M, Carmeliet P & Minchiotti G 2009 G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway. Circulation Research 105 231-238. (doi:10.1161/CIRCRESAHA.109.201186)
33. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C, Saulnier-Blache JS et al. 2006 TNFa up-regulates apelin expression in human and mouse adipose tissue. FASEB Journal 20 1528-1530. (doi:10.1096/fj.05-5243fje)
34. De Mota N, Lenkei Z & Llorens-Cortes C 2000 Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 72 400-407. (doi:10.1159/000054609)
35. De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, Kordon C, Vaudry H, Moos F & Llorens-Cortes C 2004 Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. PNAS 101 10464-10469. (doi:10.1073/pnas. 0403518101)
36. Devic E, Paquereau L, Vernier P, Knibiehler B & Audigier Y 1996 Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis. Mechanisms of Development 59 129-140. (doi:10.1016/0925-4773(96)00585-0)
37. Devic E, Rizzoti K, Bodin S, Knibiehler B & Audigier Y 1999 Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mechanisms of Development 84 199-203. (doi:10.1016/S0925-4773(99)00081-7)
38. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C et al. 2008 Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism 8 437-445. (doi:10.1016/j.cmet.2008.10.003)
39. Dray C, Debard C, Jager J,Disse E, Daviaud D, Martin P, Attane C, Wanecq E, Guigne C, Bost F et al. 2010 Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. American Journal of Physiology. Endocrinology and Metabolism 298 E1161-E1169. (doi:10.1152/ajpendo.00598.2009)
40. Duparc T, Colom A, Cani PD, Massaly N, Rastrelli S, Drougard A, Le Gonidec S, Mouledous L, Frances B, Leclercq I et al. 2011 Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Antioxidants & Redox Signaling 15 1477-1496. (doi:10.1089/ars.2010.3454)
41. Edinger AL, Hoffman TL, Sharron M, Lee B, Yi Y, Choe W, Kolson DL, Mitrovic B, Zhou Y, Faulds D et al. 1998 An orphan seventransmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. Journal of Virology 72 7934-7940.
42. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y et al. 1998 Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Journal of Biological Chemistry 273 8890-8896. (doi:10.1074/jbc.273.15.8890)
43. El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D & Llorens-Cortes C 2004 Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. Journal of Neurochemistry 90 1290-1301. (doi:10.1111/j.1471-4159. 2004.02591.x)
44. Erdem G, Dogru T, Tasci I, Sonmez A & Tapan S 2008 Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 116 289-292. (doi:10.1055/s-2007- 1004564)
45. Eyries M, Siegfried G, Ciumas M, Montagne K, Agrapart M, Lebrin F & Soubrier F 2008 Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circulation Research 103 432-440. (doi:10.1161/CIRCRESAHA.108.179333)
46. Falcone C, Bozzini S, Schirinzi S, Buzzi MP, Boiocchi C, Totaro R, Bondesan M & Pelissero G 2012 APJ polymorphisms in coronary artery disease patients with and without hypertension. Molecular Medicine Reports 5 321-325. (doi:10.3892/mmr.2011.685)
47. Fan X, Zhou N, Zhang X, Mukhtar M, Lu Z, Fang J, DuBois GC & Pomerantz RJ 2003 Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ. Biochemistry 42 10163-10168. (doi:10.1021/bi030049s)
48. Farkasfalvi K, Stagg MA, Coppen SR, Siedlecka U, Lee J, Soppa GK, Marczin N, Szokodi I, Yacoub MH & Terracciano CM 2007 Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochemical and Biophysical Research Communications 357 889-895. (doi:10.1016/j.bbrc.2007.04.017)
49. Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mayranpaa M, Sarman B, Seres L, Skoumal R et al. 2003 Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochemical and Biophysical Research Communications 308 480-485. (doi:10.1016/S0006-291X(03)01424-4)
50. Foussal C, Lairez O, Calise D, Pathak A, Guilbeau-Frugier C, Valet P, Parini A & Kunduzova O 2010 Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Letters 584 2363-2370.(doi:10.1016/j.febslet.2010.04.025)
51. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, Reaven GM, Quertermous T & Tsao PS 2007 HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. American Journal of Physiology. Endocrinology and Metabolism 293 E1590-E1596. (doi:10.1152/ajpendo.00490.2007)
52. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C, Nishizawa N, Murosaki S, Kurokawa T et al. 1999 Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochimica et Biophysica Acta 1452 25-35. (doi:10.1016/ S0167-4889(99)00114-7)
53. Hamada J, Kimura J, Ishida J, Kohda T, Morishita S, Ichihara S&Fukamizu A 2008 Evaluation of novel cyclic analogues of apelin. International Journal ofMolecularMedicine 22 547-552. (doi:10.3892/ijmm_00000054)
54. Han S, Wang G, Qiu S, de la Motte C, Wang HQ, Gomez G, Englander EW& Greeley GH Jr 2007 Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regulatory Peptides 142 131-137. (doi:10.1016/j.regpep.2007.02.002)
55. Han S, Wang G, Qi X, Lee HM, Englander EW & Greeley GH Jr 2008 A possible role for hypoxia-induced apelin expression in enteric cell proliferation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 294 R1832-R1839. (doi:10.1152/ajpregu. 00083.2008)
56. Hansen A, Chen Y, Inman JM, Phan QN, Qi ZQ, Xiang CC, Palkovits M, Cherman N, Kuznetsov SA, Robey PG et al. 2007 Sensitive and specific method for detecting G protein-coupled receptor mRNAs. Nature Methods 4 35-37. (doi:10.1038/nmeth977)
57. Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H, Ishida J, Toya Y, Kiuchi Y, Hirawa N et al. 2007 Requirement of apelin- apelin receptor system for oxidative stress-linked atherosclerosis. American Journal of Pathology 171 1705-1712. (doi:10.2353/ajpath. 2007.070471)
58. Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Iida M et al. 2007 Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Human Molecular Genetics 16 630-639. (doi:10.1093/ hmg/ddm005)
59. Hazell GG, Hindmarch CC, Pope GR, Roper JA, Lightman SL, Murphy D, O'Carroll AM & Lolait SJ 2012 G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei - serpentine gateways to neuroendocrine homeostasis. Frontiers in Neuroendocrinology 33 45-66. (doi:10.1016/j.yfrne.2011.07.002)
60. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K, Kakuma T & Yoshimatsu H 2007 Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 148 2690-2697. (doi:10.1210/en.2006-1270)
61. Horiuchi Y, Fujii T, Kamimura Y & Kawashima K 2003 The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses. Journal of Neuroimmunology 144 46-52. (doi:10.1016/j.jneuroim.2003. 08.029)
62. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T, Onda H et al. 2000 Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. Journal of Biological Chemistry 275 21061-21067. (doi:10.1074/jbc.M908417199)
63. Hu PF, Tang JL, Chen WP, Bao JP & Wu LD 2011 Increased apelin serum levels and expression in human chondrocytes in osteoarthritic patients. International Orthopaedics 35 1421-1426. (doi:10.1007/ s00264-010-1100-y)
64. Hus-Citharel A, Bouby N, Frugiere A, Bodineau L, Gasc JM & Llorens- Cortes C 2008 Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney International 74 486-494. (doi:10.1038/ki. 2008.199)
65. Huynh J, Thomas WG, Aguilar MI & Pattenden LK 2009 Role of helix 8 in G protein-coupled receptors based on structure-function studies on the type 1 angiotensin receptor. Molecular and Cellular Endocrinology 302 118-127. (doi:10.1016/j.mce.2009.01.002)
66. Inui M, Fukui A, Ito Y & Asashima M 2006 Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Developmental Biology 298 188-200. (doi:10.1016/j.ydbio.2006.06.028)
67. Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, Shiota N et al. 2004 Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensintype 1 receptor in blood pressure in vivo. Journal of Biological Chemistry 279 26274-26279. (doi:10.1074/jbc.M404149200)
68. Iturrioz X, Alvear-Perez R, De Mota N, Franchet C, Guillier F, Leroux V, Dabire H, Le Jouan M, Chabane H, Gerbier R et al. 2010 Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist. FASEB Journal 24 1506-1517. (doi:10.1096/ fj.09-140715)
69. Japp AG, Cruden NL, Amer DA, Li VK, Goudie EB, Johnston NR, Sharma S, Neilson I, Webb DJ, Megson IL et al. 2008 Vascular effects of apelin in vivo in man. Journal of the American College of Cardiology 52 908-913. (doi:10.1016/j.jacc.2008.06.013)
70. Jaszberenyi M, Bujdoso E & Telegdy G 2004 Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129 811-816. (doi:10.1016/j.neuroscience.2004.08.007)
71. Jia YX, Lu ZF, Zhang J, Pan CS, Yang JH, Zhao J, Yu F, Duan XH, Tang CS & Qi YF 2007 Apelin activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Peptides 28 2023-2029. (doi:10.1016/ j.peptides.2007.07.016)
72. Jiang H, Ye XP, Yang ZY, Zhan M, Wang HN, Cao HM, Xie HJ, Pan CM, Song HD & Zhao SX 2013 Aldosterone directly affects apelin expression and secretion in adipocytes. Journal of Molecular Endocrinology 51 37-48. (doi:10.1530/JME-13-0025)
73. Jones PG, Nawoschik SP, Sreekumar K, Uveges AJ, Tseng E, Zhang L, Johnson J, He L, Paulsen JE, Bates B et al. 2007 Tissue distribution and functional analyses of the constitutively active orphan G protein coupled receptors, GPR26 and GPR78. Biochimica et Biophysica Acta 1770 890-901. (doi:10.1016/j.bbagen.2007.01.013)
74. Kagiyama S, Fukuhara M, Matsumura K, Lin Y, Fujii K & Iida M 2005 Central and peripheral cardiovascular actions of apelin in conscious rats. Regulatory Peptides 125 55-59. (doi:10.1016/j.regpep.2004.07.033)
75. Kalin RE, Kretz MP, Meyer AM, Kispert A, Heppner FL & Brandli AW 2007 Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Developmental Biology 305 599-614. (doi:10.1016/j.ydbio.2007.03.004)
76. Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu R, McLean DL, Kim JD, Park H, Jin SW et al. 2013 Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circulation Research 113 22-31. (doi:10.1161/CIRCRESAHA.113.301324)
77. Kasai A, Shintani N, OdaM, Kakuda M, Hashimoto H,Matsuda T, Hinuma S & Baba A 2004 Apelin is a novel angiogenic factor in retinal endothelial cells. Biochemical and Biophysical Research Communications 325 395-400. (doi:10.1016/j.bbrc.2004.10.042)
78. Kasai A, Shintani N, Kato H, Matsuda S, Gomi F, Haba R, Hashimoto H, Kakuda M, Tano Y & Baba A 2008 Retardation of retinal vascular development in apelin-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 28 1717-1722. (doi:10.1161/ATVBAHA.108.163402)
79. Kasai A, Ishimaru Y, Kinjo T, Satooka T, Matsumoto N, Yoshioka Y, Yamamuro A, Gomi F, Shintani N, Baba A et al. 2010 Apelin is a crucial factor for hypoxia-induced retinal angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 30 2182-2187. (doi:10.1161/ ATVBAHA.110.209775)
80. Katugampola SD, Maguire JJ, Matthewson SR & Davenport AP 2001 [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. British Journal of Pharmacology 132 1255-1260. (doi:10.1038/sj.bjp.0703939)
81. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O et al. 2001 Molecular properties of apelin: tissue distribution and receptor binding. Biochimica et Biophysica Acta 1538 162-171. (doi:10.1016/ S0167-4889(00)00143-9)
82. Kidoya H & Takakura N 2012 Biology of the apelin-APJ axis in vascular formation. Journal of Biochemistry 152 125-131. (doi:10.1093/jb/ mvs071)
83. Kidoya H, Naito H & Takakura N 2010 Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 115 3166-3174. (doi:10.1182/blood-2009-07-232306)
84. Kim S & Iwao H 2000 Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacological Reviews 52 11-34.
85. Kleinz MJ & Baxter GF 2008 Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase. Regulatory Peptides 146 271-277. (doi:10.1016/j.regpep.2007.10.002)
86. Kleinz MJ & Davenport AP 2004 Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regulatory Peptides 118 119-125. (doi:10.1016/j.regpep.2003.11.002)
87. Kleinz MJ, Skepper JN & Davenport AP 2005 Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regulatory Peptides 126 233-240. (doi:10.1016/j.regpep.2004.10.019)
88. Kozak M 1996 Interpreting cDNA sequences: some insights from studies on translation. Mammalian Genome 7 563-574. (doi:10.1007/ s003359900171)
89. Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Schwaighofer J et al. 2007 Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circulation Research 101 e32-e42. (doi:10.1161/ CIRCRESAHA.107.158659)
90. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR & O'Dowd BF 2000 Characterization of apelin, the ligand for the APJ receptor. Journal of Neurochemistry 74 34-41. (doi:10.1046/ j.1471-4159.2000.0740034.x)
91. Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR & O'Dowd BF 2005 Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146 231-236. (doi:10.1210/ en.2004-0359)
92. Lee DK, George SR & O'Dowd BF 2006 Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends in Pharmacological Sciences 27 190-194. (doi:10.1016/ j.tips.2006.02.006)
93. Leeper NJ, Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA, Tsao PS, Dalman RL & Quertermous T 2009 Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. American Journal of Physiology. Heart and Circulatory Physiology 296 H1329-H1335. (doi:10.1152/ajpheart.01341.2008)
94. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H & Li K 2006 Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology & Diabetes 114 544-548. (doi:10.1055/s-2006- 948309)
95. Li Y, Chen J, Bai B, Du H, Liu Y & Liu H 2012 Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction. Cellular Signalling 24 991-1001. (doi:10.1016/j.cellsig.2011.12.012)
96. Liebmann C 2011 EGF receptor activation by GPCRs: an universal pathway reveals different versions. Molecular and Cellular Endocrinology 331 222-231. (doi:10.1016/j.mce.2010.04.008)
97. Liu C, Su T, Li F, Li L, Qin X, PanW, Feng F, Chen F, Liao D & Chen L 2010 PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13. Acta Biochimica et Biophysica Sinica 42 396-402. (doi:10.1093/abbs/gmq035)
98. Lv SY, Qin YJ, Wang HT, Xu N, Yang YJ & Chen Q 2012a Centrally administered apelin-13 induces depression-like behavior in mice. Brain Research Bulletin 88 574-580. (doi:10.1016/j.brainresbull.2012.06.003)
99. Lv SY, Qin YJ, Wang NB, Yang YJ & Chen Q 2012b Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model. Peptides 37 165-170. (doi:10.1016/j.peptides.2012.06.007)
100. Macaluso NJ, Pitkin SL, Maguire JJ, Davenport AP & Glen RC 2011 Discovery of a competitive apelin receptor (APJ) antagonist. ChemMedChem 6 1017-1023. (doi:10.1002/cmdc.201100069)
101. Maguire JJ, Kleinz MJ, Pitkin SL & Davenport AP 2009 [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactivemechanisms and inotropic action in disease. Hypertension 54 598-604. (doi:10.1161/HYPERTENSIONAHA.109.134619)
102. Maloney PR, Khan P, Hedrick M, Gosalia P, Milewski M, Li L, Roth GP, Sergienko E, Suyama E, Sugarman E et al. 2012 Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor. Bioorganic & Medicinal Chemistry Letters 22 6656-6660. (doi:10.1016/ j.bmcl.2012.08.105)
103. Marc Y & Llorens-Cortes C 2011 The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Progress in Neurobiology 95 89-103. (doi:10.1016/j.pneurobio.2011.06.006)
104. Margulies BJ, Hauer DA & Clements JE 2001 Identification and comparison of eleven rhesus macaque chemokine receptors. AIDS Research and Human Retroviruses 17 981-986. (doi:10.1089/088922201750290104)
105. Masri B, Lahlou H, Mazarguil H, Knibiehler B & Audigier Y 2002 Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochemical and Biophysical Research Communications 290 539-545. (doi:10.1006/bbrc.2001.6230)
106. Masri B, Morin N, Cornu M, Knibiehler B & Audigier Y 2004 Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB Journal 18 1909-1911. (doi:10.1096/fj.04-1930fje)
107. Masri B, Morin N, Pedebernade L, Knibiehler B & Audigier Y 2006 The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. Journal of Biological Chemistry 281 18317-18326. (doi:10.1074/jbc.M600606200)
108. Matsumoto M, Hidaka K, Akiho H, Tada S, Okada M & Yamaguchi T 1996 Low stringency hybridization study of the dopamine D4 receptor revealed D4-like mRNA distribution of the orphan seventransmembrane receptor, APJ, in human brain. Neuroscience Letters 219 119-122. (doi:10.1016/S0304-3940(96)13198-0)
109. Mazzucotelli A, Ribet C, Castan-Laurell I, Daviaud D, Guigne C, Langin D & Valet P 2008 The transcriptional co-activator PGC-1a up regulates apelin in human and mouse adipocytes. Regulatory Peptides 150 33-37. (doi:10.1016/j.regpep.2008.04.003)
110. McKenzie JA, Fruttiger M, Abraham S, Lange CA, Stone J, Gandhi P, Wang X, Bainbridge J, Moss SE & Greenwood J 2012 Apelin is required for non-neovascular remodeling in the retina. American Journal of Pathology 180 399-409. (doi:10.1016/j.ajpath.2011.09.035)
111. Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE et al. 2003 Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. Journal of Neurochemistry 84 1162-1172. (doi:10.1046/j.1471-4159.2003.01587.x)
112. Miettinen KH, Magga J, Vuolteenaho O, Vanninen EJ, Punnonen KR, Ylitalo K, Tuomainen P & Peuhkurinen KJ 2007 Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy. Regulatory Peptides 140 178-184. (doi:10.1016/j.regpep.2006.12.004)
113. Mitra A, Katovich MJ, Mecca A & Rowland NE 2006 Effects of central and peripheral injections of apelin on fluid intake and cardiovascular parameters in rats. Physiology & Behavior 89 221-225. (doi:10.1016/ j.physbeh.2006.06.006)
114. Newson MJ, Roberts EM, Pope GR, Lolait SJ & O'Carroll AM 2009 The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms. Journal of Endocrinology 202 123-129. (doi:10.1677/JOE-09-0093)
115. Newson MJ, Pope GR, Roberts EM, Lolait SJ & O'Carroll AM 2013 Stressdependent and gender-specific neuroregulatory roles of the apelin receptor in the hypothalamic-pituitary-adrenal axis response to acute stress. Journal of Endocrinology 216 99-109. (doi:10.1530/JOE-12-0375)
116. NiuW,Wu S, Zhang Y, Li W, Ji K, Gao P & Zhu D 2010 Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population. Journal of Hypertension 28 1854-1861. (doi:10.1097/HJH.0b013e32833b1fad)
117. O'Carroll AM & Lolait SJ 2003 Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli. Journal of Neuroendocrinology 15 661-666. (doi:10.1046/j.1365-2826. 2003.01044.x)
118. O'Carroll AM, Selby TL, Palkovits M& Lolait SJ 2000 Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochimica et Biophysica Acta 1492 72-80. (doi:10.1016/S0167-4781(00)00072-5)
119. O'Carroll AM, Don AL & Lolait SJ 2003 APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. Journal of Neuroendocrinology 15 1095-1101. (doi:10.1046/j.1365-2826.2003.01102.x)
120. O'Carroll AM, Lolait SJ & Howell GM 2006 Transcriptional regulation of the rat apelin receptor gene: promoter cloning and identification of an Sp1 site necessary for promoter activity. Journal of Molecular Endocrinology 36 221-235. (doi:10.1677/jme.1.01927)
121. O'Donnell LA, Agrawal A, Sabnekar P, Dichter MA, Lynch DR & Kolson DL 2007 Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. Journal of Neurochemistry 102 1905-1917. (doi:10.1111/j.1471-4159.2007.04645.x)
122. O'Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR & Nguyen T 1993 A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 355-360. (doi:10.1016/0378- 1119(93)90495-O)
123. Ohno S, Yakabi K, Ro S, Ochiai M, Onouchi T, Sakurada T, Takabayashi H, Ishida S & Takayama K 2012 Apelin-12 stimulates acid secretion through an increase of histamine release in rat stomachs. Regulatory Peptides 174 71-78. (doi:10.1016/j.regpep.2011.12.002)
124. Olszanecka-Glinianowicz M, Madej P, Nylec M, Owczarek A, Szanecki W, Skalba P & Chudek J 2012 Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clinical Endocrinology 79 238-242. (doi:10.1111/cen.12120)
125. Ostrom RS & Insel PA 2004 The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. British Journal of Pharmacology 143 235-245. (doi:10.1038/sj.bjp.0705930)
126. Piairo P, Moura RS, Nogueira-Silva C & Correia-Pinto J 2011 The apelinergic system in the developing lung: expression and signaling. Peptides 32 2474-2483. (doi:10.1016/j.peptides.2011.10.010)
127. Pitkin S MN, Maguire J, Glen R & Davenport A 2009 Role for Apelin in Human Atherosclerosis and Discovery of Novel Agonists for Its Receptor APJ. In Proceedings of the British Pharmacological Society at http://www.pA2online.org/abstracts/Vol7Issue4abst027P.pdf.
128. Pitkin SL, Maguire JJ, Kuc RE & Davenport AP 2010 Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. British Journal of Pharmacology 160 1785-1795. (doi:10.1111/j.1476-5381. 2010.00821.x)
129. Pope GR, Roberts EM, Lolait SJ & O'Carroll AM 2012 Central and peripheral apelin receptor distribution in the mouse: species differences with rat. Peptides 33 139-148. (doi:10.1016/j.peptides.2011.12.005)
130. Poulain DA, Wakerley JB & Dyball RE 1977 Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones. Proceedings of the Royal Society of London. Series B. Biological Sciences 196 367-384. (doi:10.1098/rspb.1977.0046)
131. Principe A, Melgar-Lesmes P, Fernandez-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V & Jimenez W 2008 The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 48 1193-1201. (doi:10.1002/hep.22467)
132. Puffer BA, Sharron M, Coughlan CM, Baribaud F, McManus CM, Lee B, David J, Price K, Horuk R, TsangMet al. 2000 Expression and coreceptor function of APJ for primate immunodeficiency viruses. Virology 276 435-444. (doi:10.1006/viro.2000.0557)
133. Rapoport TA 2007 Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes. Nature 450 663-669. (doi:10.1038/nature06384)
134. ReauxA,De MotaN, Skultetyova I, Lenkei Z, ElMessari S, GallatzK, Corvol P, Palkovits M & Llorens-Cortes C 2001 Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. Journal of Neurochemistry 77 1085-1096. (doi:10.1046/j.1471-4159.2001.00320.x)
135. Reaux A, Gallatz K, Palkovits M & Llorens-Cortes C 2002 Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113 653-662. (doi:10.1016/S0306-4522(02)00192-6)
136. Reaux-Le Goazigo A, Morinville A, Burlet A, Llorens-Cortes C & Beaudet A 2004 Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145 4392-4400. (doi:10.1210/en.2004-0384)
137. Reaux-Le Goazigo A, Alvear-Perez R, Zizzari P, Epelbaum J, Bluet-Pajot MT & Llorens-Cortes C 2007 Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release. American Journal of Physiology. Endocrinology and Metabolism 292 E7-E15. (doi:10.1152/ajpendo.00521.2005)
138. Regard JB, Sato IT & Coughlin SR 2008 Anatomical profiling of G proteincoupled receptor expression. Cell 135 561-571. (doi:10.1016/j.cell. 2008.08.040)
139. Roberts EM, Newson MJ, Pope GR, Landgraf R, Lolait SJ & O'Carroll AM 2009 Abnormal fluid homeostasis in apelin receptor knockout mice. Journal of Endocrinology 202 453-462. (doi:10.1677/JOE-09-0134)
140. Roberts EM, Pope GR, Newson MJ, Landgraf R, Lolait SJ & O'Carroll AM 2010 Stimulus-specific neuroendocrine responses to osmotic challenges in apelin receptor knockout mice. Journal of Neuroendocrinology 22 301-308. (doi:10.1111/j.1365-2826.2010.01968.x)
141. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O & Tavi P 2007 Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB Journal 21 1821-1830. (doi:10.1096/fj.06-7294com)
142. Salcedo A, Garijo J, Monge L, Fernandez N, Luis Garcia-Villalon A, Sanchez Turrion V, Cuervas-Mons V & Dieguez G 2007 Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids. Regulatory Peptides 144 50-55. (doi:10.1016/j.regpep.2007.06.005)
143. Sarzani R, Forleo C, Pietrucci F, Capestro A, Soura E, Guida P, Sorrentino S, Iacoviello M, Romito R, Dessi-Fulgheri P et al. 2007 The 212A variant of the APJ receptor gene for the endogenous inotrope apelin is associated with slower heart failure progression in idiopathic dilated cardiomyopathy. Journal of Cardiac Failure 13 521-529. (doi:10.1016/j.cardfail. 2007.04.002)
144. Sato K, Takahashi T, Kobayashi Y, Hagino A, Roh SG & Katoh K 2012 Apelin is involved in postprandial responses and stimulates secretion of arginine-vasopressin, adrenocorticotropic hormone, and growth hormone in the ruminant. Domestic Animal Endocrinology 42 165-172. (doi:10.1016/j.domaniend.2011.11.006)
145. Schilffarth S, Antoni B, Schams D, Meyer HH & Berisha B 2009 The expression of apelin and its receptor APJ during different physiological stages in the bovine ovary. International Journal of Biological Sciences 5 344-350. (doi:10.7150/ijbs.5.344)
146. ScimiaMC,HurtadoC,RayS,Metzler S,WeiK,Wang J,WoodsCE,PurcellNH, Catalucci D, Akasaka T et al. 2012 APJ acts as a dual receptor in cardiac hypertrophy. Nature 488 394-398. (doi:10.1038/nature11263)
147. Seyedabadi M, Goodchild AK & Pilowsky PM 2002 Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Autonomic Neuroscience 101 32-38. (doi:10.1016/ S1566-0702(02)00178-9)
148. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA et al. 2008 In vivo genetic profiling and cellular localization of apelin reveals a hypoxiasensitive, endothelial-centered pathway activated in ischemic heart failure. American Journal of Physiology. Heart and Circulatory Physiology 294 H88-H98. (doi:10.1152/ajpheart.00935.2007)
149. Shonberg J, Scammells PJ & Capuano B 2011 Design strategies for bivalent ligands targeting GPCRs. ChemMedChem 6 963-974. (doi:10.1002/ cmdc.201100101)
150. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM & Smith CC 2007 Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Research in Cardiology 102 518-528. (doi:10.1007/s00395-007-0671-2)
151. Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, Cooper MB & Yellon DM2007 Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin. Cardiovascular Drugs and Therapy 21 409-414. (doi:10.1007/s10557-007-6054-y)
152. Sonmez A, Celebi G, Erdem G, Tapan S, Genc H, Tasci I, Ercin CN, Dogru T, Kilic S, Uckaya G et al. 2010 Plasma apelin and ADMA levels in patients with essential hypertension. Clinical and Experimental Hypertension 32 179-183. (doi:10.3109/10641960903254505)
153. Sorhede Winzell M, Magnusson C & Ahren B 2005 The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regulatory Peptides 131 12-17. (doi:10.1016/j.regpep. 2005.05.004)
154. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ & Garcia-Fuentes E 2009 Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obesity Surgery 19 1574-1580. (doi:10.1007/s11695-009-9955-y)
155. Sorli SC, van den Berghe L, Masri B, Knibiehler B & Audigier Y 2006 Therapeutic potential of interfering with apelin signalling. Drug Discovery Today 11 1100-1106. (doi:10.1016/j.drudis.2006.10.011)
156. Sorli SC, Le Gonidec S, Knibiehler B & Audigier Y 2007 Apelin is a potent activator of tumour neoangiogenesis. Oncogene 26 7692-7699. (doi:10.1038/sj.onc.1210573)
157. Susaki E, Wang G, Cao G, Wang HQ, Englander EW & Greeley GH Jr 2005 Apelin cells in the rat stomach. Regulatory Peptides 129 37-41. (doi:10.1016/j.regpep.2005.01.013)
158. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M et al. 2002 Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circulation Research 91 434-440. (doi:10.1161/01.RES. 0000033522.37861.69)
159. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, GhateiM& Bloom S 2002 The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochemical and Biophysical Research Communications 291 1208-1212. (doi:10.1006/bbrc.2002.6575)
160. Tanaka S, Ishii K, Kasai K, Yoon SO & Saeki Y 2007 Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth. Journal of Biological Chemistry 282 10506-10515. (doi:10.1074/jbc.M700911200)
161. Tang SY, Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Zhou HD, Wu XP & Liao EY 2007 Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways. Peptides 28 708-718. (doi:10.1016/j.peptides.2006. 10.005)
162. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C et al. 1998 Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 251 471-476. (doi:10.1006/bbrc.1998.9489)
163. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K & Fujimiya M 2001 The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regulatory Peptides 99 87-92. (doi:10.1016/S0167-0115(01)00236-1)
164. Telegdy G, Adamik A & Jaszberenyi M 2013 Involvement of neurotransmitters in the action of apelin-13 on passive avoidance learning in mice. Peptides 39 171-174. (doi:10.1016/j.peptides.2012.10.011)
165. Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, Berzigotti A, Bosch J & FernandezM2009 Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. Journal of Hepatology 50 296-305. (doi:10.1016/ j.jhep.2008.09.019)
166. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G & Turner AJ 2000 A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry 275 33238-33243. (doi:10.1074/ jbc.M002615200)
167. Tobin VA, Bull PM, Arunachalam S, O'Carroll AM, Ueta Y & LudwigM2008 The effects of apelin on the electrical activity of hypothalamic magnocellular vasopressin and oxytocin neurons and somatodendritic peptide release. Endocrinology 149 6136-6145. (doi:10.1210/ en.2008-0178)
168. Tucker B, Hepperle C, Kortschak D, Rainbird B, Wells S, Oates AC & Lardelli M 2007 Zebrafish angiotensin II receptor-like 1a (agtrl1a) is expressed in migrating hypoblast, vasculature, and in multiple embryonic epithelia. Gene Expression Patterns 7 258-265. (doi:10.1016/j.modgep.2006.09.006)
169. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M & Telser J 2007 Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 39 44-84. (doi:10.1016/j.biocel.2006.07.001)
170. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F et al. 2002 Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Journal of Biological Chemistry 277 14838-14843. (doi:10.1074/jbc.M200581200)
171. Wang G, Anini Y, Wei W, Qi X, AM OCarroll, Mochizuki T, Wang HQ, Hellmich MR, Englander EW & Greeley GH Jr 2004 Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 145 1342-1348. (doi:10.1210/en.2003-1116)
172. Wang G, Qi X, Wei W, Englander EW & Greeley GH Jr 2006 Characterization of the 50-regulatory regions of the rat and human apelin genes and regulation of breast apelin by USF. FASEB Journal 20 2639-2641. (doi:10.1096/fj.06-6315fje)
173. Wang G, Kundu R, Han S, Qi X, Englander EW, Quertermous T & Greeley GH Jr 2009 Ontogeny of apelin and its receptor in the rodent gastrointestinal tract. Regulatory Peptides 158 32-39. (doi:10.1016/ j.regpep.2009.07.016)
174. Wattanachanya L, Lu WD, Kundu RK, Wang L, Abbott MJ, O'Carroll D, Quertermous T & Nissenson RA 2013 Increased bone mass in mice lacking the adipokine apelin. Endocrinology 154 2069-2080. (doi:10.1210/en.2012-2034)
175. Wei L, Hou X & Tatemoto K 2005 Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regulatory Peptides 132 27-32. (doi:10.1016/j.regpep.2005.08.003)
176. Wheatley M & Hawtin SR 1999 Glycosylation of G-protein-coupled receptors for hormones central to normal reproductive functioning: its occurrence and role. Human Reproduction Update 5 356-364. (doi:10.1093/humupd/5.4.356)
177. Xia Y & Krukoff TL 2003 Differential neuronal activation in the hypothalamic paraventricular nucleus and autonomic/neuroendocrine responses to i.c.v. endotoxin. Neuroscience 121 219-231. (doi:10.1016/ S0306-4522(03)00290-2)
178. XieH, Tang SY, Cui RR, Huang J, Ren XH, Yuan LQ, Lu Y, Yang M, Zhou HD, Wu XP et al. 2006 Apelin and its receptor are expressed in human osteoblasts. Regulatory Peptides 134 118-125. (doi:10.1016/j.regpep. 2006.02.004)
179. Xie H, Yuan LQ, Luo XH, Huang J, Cui RR, Guo LJ, Zhou HD, Wu XP & Liao EY 2007 Apelin suppresses apoptosis of human osteoblasts. Apoptosis 12 247-254. (doi:10.1007/s10495-006-0489-7)
180. Xu N, Wang H, Fan L & Chen Q 2009 Supraspinal administration of apelin-13 induces antinociception via the opioid receptor in mice. Peptides 30 1153-1157. (doi:10.1016/j.peptides.2009.02.011)
181. Yao F, Modgil A, Zhang Q, Pingili A, Singh N, O'Rourke ST & Sun C 2011 Pressor effect of apelin-13 in the rostral ventrolateral medulla: role of NAD(P)H oxidase-derived superoxide. Journal of Pharmacology and Experimental Therapeutics 336 372-380. (doi:10.1124/jpet.110.174102)
182. Yue P, Jin H, Aillaud M, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T & Tsao PS 2010 Apelin is necessary for the maintenance of insulin sensitivity. American Journal of Physiology. Endocrinology and Metabolism 298 E59-E67. (doi:10.1152/ajpendo. 00385.2009)
183. Zeng XJ, Zhang LK, Wang HX, Lu LQ, Ma LQ & Tang CS 2009 Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 30 1144-1152. (doi:10.1016/j.peptides.2009.02.010)
184. Zeng XJ, Yu SP, Zhang L & Wei L 2010 Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Experimental Cell Research 316 1773-1783. (doi:10.1016/j.yexcr.2010. 02.005)
185. Zhang YJ, Dragic T, Cao Y, Kostrikis L, Kwon DS, Littman DR, KewalRamani VN & Moore JP 1998 Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. Journal of Virology 72 9337-9344.
186. Zhang Q, Yao F, Raizada MK, O'Rourke ST & Sun C 2009 Apelin gene transfer into the rostral ventrolateral medulla induces chronic blood pressure elevation in normotensive rats. Circulation Research 104 1421-1428. (doi:10.1161/CIRCRESAHA.108.192302)
187. Zhao Q, Hixson JE, Rao DC, Gu D, Jaquish CE, Rice T, Shimmin LC, Chen J, Cao J, Kelly TN et al. 2010 Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study. Journal of Hypertension 28 756-763. (doi:10.1097/HJH.0b013e3283370d32)
188. Zhong JC, Yu XY, Huang Y, Yung LM, Lau CW & Lin SG 2007 Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovascular Research 74 388-395. (doi:10.1016/j.cardiores.2007.02.002)
189. Zhou H, Li XM, Meinkoth J & Pittman RN 2000 Akt regulates cell survival and apoptosis at a postmitochondrial level. Journal of Cell Biology 151 483-494. (doi:10.1083/jcb.151.3.483)
190. Zhou N, Fan X, Mukhtar M, Fang J, Patel CA, DuBois GC & Pomerantz RJ 2003a Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ. Journal of Virology 307 22-36. (doi:10.1016/S0042- 6822(02)00021-1)
191. Zhou N, Fang J, Acheampong E, MukhtarM& Pomerantz RJ 2003b Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1. Virology 312 196-203. (doi:10.1016/S0042- 6822(03)00185-5)
192. Zhou N, Zhang X, Fan X, Argyris E, Fang J, Acheampong E, DuBois GC & Pomerantz RJ 2003c The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity. Virology 317 84-94. (doi:10.1016/j.virol.2003.08.026)
193. Zhu S, Sun F, Li W, Cao Y, Wang C, Wang Y, Liang D, Zhang R, Zhang S, Wang H et al. 2011 Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Molecular and Cellular Biochemistry 353 305-313. (doi:10.1007/ s11010-011-0799-0)
194. Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K & Hoshino H 2000 Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Letters 473 15-18. (doi:10.1016/S0014-5793(00)01487-3)